TIBSOVO (ivosidenib), an IDH1 Inhibitor Approved for Treatment of Relapsed/Refractory Acute Myeloid Leukemia with an IDH1 Mutation, Available for Order at Biologics by McKesson
CARY, N.C. (July 23, 2018) — Biologics by McKesson, an independent specialty pharmacy for oncology and other complex therapeutic areas, has […]